A citation-based method for searching scientific literature

Samuel W Brady, Alexander M Gout, Jinghui Zhang. Trends Genet 2022
Times Cited: 11







List of co-cited articles
32 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Signatures of mutational processes in human cancer.
Ludmil B Alexandrov, Serena Nik-Zainal, David C Wedge, Samuel A J R Aparicio, Sam Behjati, Andrew V Biankin, Graham R Bignell, Niccolò Bolli, Ake Borg, Anne-Lise Børresen-Dale,[...]. Nature 2013
45

The repertoire of mutational signatures in human cancer.
Ludmil B Alexandrov, Jaegil Kim, Nicholas J Haradhvala, Mi Ni Huang, Alvin Wei Tian Ng, Yang Wu, Arnoud Boot, Kyle R Covington, Dmitry A Gordenin, Erik N Bergstrom,[...]. Nature 2020
45

Mutational processes molding the genomes of 21 breast cancers.
Serena Nik-Zainal, Ludmil B Alexandrov, David C Wedge, Peter Van Loo, Christopher D Greenman, Keiran Raine, David Jones, Jonathan Hinton, John Marshall, Lucy A Stebbings,[...]. Cell 2012
36

Deciphering signatures of mutational processes operative in human cancer.
Ludmil B Alexandrov, Serena Nik-Zainal, David C Wedge, Peter J Campbell, Michael R Stratton. Cell Rep 2013
719
27



Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder.
Yaoting Gui, Guangwu Guo, Yi Huang, Xueda Hu, Aifa Tang, Shengjie Gao, Renhua Wu, Chao Chen, Xianxin Li, Liang Zhou,[...]. Nat Genet 2011
539
18

Cancer Statistics, 2021.
Rebecca L Siegel, Kimberly D Miller, Hannah E Fuchs, Ahmedin Jemal. CA Cancer J Clin 2021
18

SomaticSignatures: inferring mutational signatures from single-nucleotide variants.
Julian S Gehring, Bernd Fischer, Michael Lawrence, Wolfgang Huber. Bioinformatics 2015
203
18

Telomerase Reverse Transcriptase (TERT) Regulation in Thyroid Cancer: A Review.
Brittany A McKelvey, Christopher B Umbricht, Martha A Zeiger. Front Endocrinol (Lausanne) 2020
19
18

Whole-Exome Sequencing of Matched Primary and Metastatic Papillary Thyroid Cancer.
Tariq Masoodi, Abdul K Siraj, Sarah Siraj, Saud Azam, Zeeshan Qadri, Wafaa N Albalawy, Sandeep Kumar Parvathareddy, Saif S Al-Sobhi, Fouad Al-Dayel, Fowzan S Alkuraya,[...]. Thyroid 2020
23
18

EMu: probabilistic inference of mutational processes and their localization in the cancer genome.
Andrej Fischer, Christopher J R Illingworth, Peter J Campbell, Ville Mustonen. Genome Biol 2013
68
18

The therapeutic significance of mutational signatures from DNA repair deficiency in cancer.
Jennifer Ma, Jeremy Setton, Nancy Y Lee, Nadeem Riaz, Simon N Powell. Nat Commun 2018
111
18

Hypermutation in human cancer genomes: footprints and mechanisms.
Steven A Roberts, Dmitry A Gordenin. Nat Rev Cancer 2014
276
18

Evolution and Impact of Subclonal Mutations in Papillary Thyroid Cancer.
Tariq Masoodi, Abdul K Siraj, Sarah Siraj, Saud Azam, Zeeshan Qadri, Sandeep K Parvathareddy, Saif S Al-Sobhi, Mohammed AlDawish, Fowzan S Alkuraya, Khawla S Al-Kuraya. Am J Hum Genet 2019
15
18

Mechanisms underlying mutational signatures in human cancers.
Thomas Helleday, Saeed Eshtad, Serena Nik-Zainal. Nat Rev Genet 2014
509
18

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Bryan R Haugen, Erik K Alexander, Keith C Bible, Gerard M Doherty, Susan J Mandel, Yuri E Nikiforov, Furio Pacini, Gregory W Randolph, Anna M Sawka, Martin Schlumberger,[...]. Thyroid 2016
18

DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution.
Rachel Rosenthal, Nicholas McGranahan, Javier Herrero, Barry S Taylor, Charles Swanton. Genome Biol 2016
626
18


Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples.
Kristian Cibulskis, Michael S Lawrence, Scott L Carter, Andrey Sivachenko, David Jaffe, Carrie Sougnez, Stacey Gabriel, Matthew Meyerson, Eric S Lander, Gad Getz. Nat Biotechnol 2013
18

Learning mutational signatures and their multidimensional genomic properties with TensorSignatures.
Harald Vöhringer, Arne Van Hoeck, Edwin Cuppen, Moritz Gerstung. Nat Commun 2021
12
18

Mutational signatures: emerging concepts, caveats and clinical applications.
Gene Koh, Andrea Degasperi, Xueqing Zou, Sophie Momen, Serena Nik-Zainal. Nat Rev Cancer 2021
45
18

Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma.
Xiang Chen, Armita Bahrami, Alberto Pappo, John Easton, James Dalton, Erin Hedlund, David Ellison, Sheila Shurtleff, Gang Wu, Lei Wei,[...]. Cell Rep 2014
435
18

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
18

Maftools: efficient and comprehensive analysis of somatic variants in cancer.
Anand Mayakonda, De-Chen Lin, Yassen Assenov, Christoph Plass, H Phillip Koeffler. Genome Res 2018
18

High expression of PD-1 ligands is associated with kataegis mutational signature and APOBEC3 alterations.
Amélie Boichard, Igor F Tsigelny, Razelle Kurzrock. Oncoimmunology 2017
46
18

HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures.
Helen Davies, Dominik Glodzik, Sandro Morganella, Lucy R Yates, Johan Staaf, Xueqing Zou, Manasa Ramakrishna, Sancha Martin, Sandrine Boyault, Anieta M Sieuwerts,[...]. Nat Med 2017
493
18

Landscape of somatic mutations in 560 breast cancer whole-genome sequences.
Serena Nik-Zainal, Helen Davies, Johan Staaf, Manasa Ramakrishna, Dominik Glodzik, Xueqing Zou, Inigo Martincorena, Ludmil B Alexandrov, Sancha Martin, David C Wedge,[...]. Nature 2016
18

The mutational footprints of cancer therapies.
Oriol Pich, Ferran Muiños, Martijn Paul Lolkema, Neeltje Steeghs, Abel Gonzalez-Perez, Nuria Lopez-Bigas. Nat Genet 2019
110
18

Mutational signatures associated with tobacco smoking in human cancer.
Ludmil B Alexandrov, Young Seok Ju, Kerstin Haase, Peter Van Loo, Iñigo Martincorena, Serena Nik-Zainal, Yasushi Totoki, Akihiro Fujimoto, Hidewaki Nakagawa, Tatsuhiro Shibata,[...]. Science 2016
562
18

Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors.
Jaegil Kim, Kent W Mouw, Paz Polak, Lior Z Braunstein, Atanas Kamburov, David J Kwiatkowski, Jonathan E Rosenberg, Eliezer M Van Allen, Alan D'Andrea, Gad Getz. Nat Genet 2016
234
18

Clock-like mutational processes in human somatic cells.
Ludmil B Alexandrov, Philip H Jones, David C Wedge, Julian E Sale, Peter J Campbell, Serena Nik-Zainal, Michael R Stratton. Nat Genet 2015
535
18


Predicting immunotherapy response through genomics.
Marina Candido Visontai Cormedi, Eliezer M Van Allen, Leandro Machado Colli. Curr Opin Genet Dev 2021
9
11

Epigenetic Treatment of Urothelial Carcinoma Cells Sensitizes to Cisplatin Chemotherapy and PARP Inhibitor Treatment.
Sophia Thy, Alexandra Hommel, Sarah Meneceur, Anna L Bartkowiak, Wolfgang A Schulz, Günter Niegisch, Michèle J Hoffmann. Cancers (Basel) 2021
2
50

Genomic Signatures Predict the Immunogenicity of BRCA-Deficient Breast Cancer.
Adam A Kraya, Kara N Maxwell, Bradley Wubbenhorst, Brandon M Wenz, John Pluta, Andrew J Rech, Liza M Dorfman, Nicole Lunceford, Amanda Barrett, Nandita Mitra,[...]. Clin Cancer Res 2019
47
9

Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up.
Y Fradet, J Bellmunt, D J Vaughn, J L Lee, L Fong, N J Vogelzang, M A Climent, D P Petrylak, T K Choueiri, A Necchi,[...]. Ann Oncol 2019
213
9

APOBEC-mediated mutagenesis in urothelial carcinoma is associated with improved survival, mutations in DNA damage response genes, and immune response.
Alexander P Glaser, Damiano Fantini, Yiduo Wang, Yanni Yu, Kalen J Rimar, Joseph R Podojil, Stephen D Miller, Joshua J Meeks. Oncotarget 2017
60
9

The Current Status and Future Role of the Phosphoinositide 3 Kinase/AKT Signaling Pathway in Urothelial Cancer: An Old Pathway in the New Immunotherapy Era.
Sandy T Liu, Gavin Hui, Colleen Mathis, Karim Chamie, Allan J Pantuck, Alexandra Drakaki. Clin Genitourin Cancer 2018
34
9

Tumor Mutational Burden as a Predictive Biomarker for Response to Immune Checkpoint Inhibitors: A Review of Current Evidence.
Samuel J Klempner, David Fabrizio, Shalmali Bane, Marcia Reinhart, Tim Peoples, Siraj M Ali, Ethan S Sokol, Garrett Frampton, Alexa B Schrock, Rachel Anhorn,[...]. Oncologist 2020
133
9

APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development.
Stephen Henderson, Ankur Chakravarthy, Xiaoping Su, Chris Boshoff, Tim Robert Fenton. Cell Rep 2014
237
9

Treatment resistance in urothelial carcinoma: an evolutionary perspective.
Panagiotis J Vlachostergios, Bishoy M Faltas. Nat Rev Clin Oncol 2018
27
9

Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting.
Hirokazu Matsushita, Matthew D Vesely, Daniel C Koboldt, Charles G Rickert, Ravindra Uppaluri, Vincent J Magrini, Cora D Arthur, J Michael White, Yee-Shiuan Chen, Lauren K Shea,[...]. Nature 2012
826
9

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.
Ethan Cerami, Jianjiong Gao, Ugur Dogrusoz, Benjamin E Gross, Selcuk Onur Sumer, Bülent Arman Aksoy, Anders Jacobsen, Caitlin J Byrne, Michael L Heuer, Erik Larsson,[...]. Cancer Discov 2012
9

Combination therapy in advanced urothelial cancer: the role of PARP, HER-2 and mTOR inhibitors.
Veronica Mollica, Ilaria Maggio, Antonio Lopez-Beltran, Rodolfo Montironi, Alessia Cimadamore, Liang Cheng, Alessandro Rizzo, Francesca Giunchi, Riccardo Schiavina, Michelangelo Fiorentino,[...]. Expert Rev Anticancer Ther 2020
9
11

Immune checkpoint blockade resistance-related B2M hotspot mutations in microsatellite-unstable colorectal carcinoma.
Su Yeon Yeon, Seung-Hyun Jung, Yun Sol Jo, Eun Ji Choi, Min Sung Kim, Yeun-Jun Chung, Sug Hyung Lee. Pathol Res Pract 2019
22
9

Genetics and immunology: reinvigorated.
Alexandra Snyder, Vladimir Makarov, Matthew Hellmann, Naiyer Rizvi, Taha Merghoub, Jedd D Wolchok, Timothy A Chan. Oncoimmunology 2015
7
14

Phosphoinositide 3-Kinase Signaling Can Modulate MHC Class I and II Expression.
Sanjay Chandrasekaran, Maiko Sasaki, Christopher D Scharer, Haydn T Kissick, Dillon G Patterson, Kelly R Magliocca, John T Seykora, Bishu Sapkota, David A Gutman, Lee A Cooper,[...]. Mol Cancer Res 2019
25
9

Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer.
Hans von der Maase, Lisa Sengelov, James T Roberts, Sergio Ricci, Luigi Dogliotti, T Oliver, Malcolm J Moore, Annamaria Zimmermann, Michael Arning. J Clin Oncol 2005
9

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.
Jianjiong Gao, Bülent Arman Aksoy, Ugur Dogrusoz, Gideon Dresdner, Benjamin Gross, S Onur Sumer, Yichao Sun, Anders Jacobsen, Rileen Sinha, Erik Larsson,[...]. Sci Signal 2013
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.